EV/EBITDA
-6.42
-0.16-2.56%
10 min ago
Summary
- As of February 8, 2025, KAPA EV/EBITDA is -6.42, with a fall of -0.16 (-2.56%) during the most recent trading day.
- KAPA EV/EBITDA is now -65.89% below its all-time high of -3.87.
Performance
KAPA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
KAPA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.6% | +2.5% | +2.1% |
| 1 m1 month | +3.9% | -4.0% | -3.3% |
| 3 m3 months | -7.2% | +7.1% | +5.8% |
| 6 m6 months | - | - | - |
| ytdytd | +5.5% | -5.5% | -4.6% |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
KAPA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -65.9% | -10.76 | +40.3% | |
| 3 m | 3-month | -3.87 | -65.9% | -10.76 | +40.3% |
| 6 m | 6-month | -3.87 | -65.9% | -18.54 | +65.4% |
| 1 y | 1-year | -3.87 | -65.9% | -18.54 | +65.4% |
| 3 y | 3-year | -3.87 | -65.9% | -18.54 | +65.4% |
| 5 y | 5-year | -3.87 | -65.9% | -18.54 | +65.4% |
| alltime | all time | -3.87 | -65.9% | -18.54 | +65.4% |
Kairos Pharma EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -6.42(-5.4%) |
| Date | Value |
|---|---|
| 2024 | -6.79 |
FAQ
- What is Kairos Pharma EV/EBITDA?
- What is the all time high EV/EBITDA for Kairos Pharma?
- What is KAPA EV/EBITDA year-to-date change?
What is Kairos Pharma EV/EBITDA?
The current EV/EBITDA of KAPA is -6.42
What is the all time high EV/EBITDA for Kairos Pharma?
Kairos Pharma all-time high EV/EBITDA is -3.87
What is KAPA EV/EBITDA year-to-date change?
Kairos Pharma EV/EBITDA has changed by +0.37 (+5.45%) since the beginning of the year